Glycation of HDL blunts its anti-inflammatory and cholesterol efflux capacities in vitro, but has no effect in poorly controlled type 1 diabetes subjects-Reference-Cited by-同舟云学术

Glycation of HDL blunts its anti-inflammatory and cholesterol efflux capacities in vitro, but has no effect in poorly controlled type 1 diabetes subjects

Published:2020-12 Issue:12 Volume:34 Page:107693
ISSN:1056-8727
Container-title:Journal of Diabetes and its Complications
language:en
Short-container-title:Journal of Diabetes and its Complications

Author:

Gomes Kjerulf Diego,Wang Shari,Omer Mohamed,Pathak Asha,Subramanian Savitha,Han Chang Yeop,Tang Chongren,den Hartigh Laura J.,Shao Baohai,Chait Alan

Funder

NIH

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference38 articles.

1. Molecular mechanisms of ROS production and oxidative stress in diabetes;Newsholme;Biochem J,2016

2. The role of high-density lipoproteins in diabetes and its vascular complications;Wong;Int J Mol Sci,2018

3. Biochemistry and molecular cell biology of diabetic complications;Brownlee;Nature,2001

4. Role of advanced glycation end products in cellular signaling;Ott;Redox Biol,2014

5. A glycation angle to look into the diabetic vasculopathy: cause and cure;Ahmad;Curr Vasc Pharmacol,2017

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The remarkable similarity in the serum proteome between type 2 diabetics and controls;2024-03-22

2. Antioxidant and Anti-Inflammatory Functions of High-Density Lipoprotein in Type 1 and Type 2 Diabetes;Antioxidants;2023-12-28

3. Determinants of incident atherosclerotic cardiovascular disease events among individuals with type 2 diabetic microvascular complications in the UK: a prospective cohort study;Diabetology & Metabolic Syndrome;2023-08-29

4. Optimizing glycation control in diabetes: An integrated approach for inhibiting nonenzymatic glycation reactions of biological macromolecules;International Journal of Biological Macromolecules;2023-07

5. High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity;Metabolites;2023-02-09